India to France: Albendazole Export Trade Route
India has recorded 314 verified shipments of Albendazole exported to France, representing a combined trade value of $5.8M USD. This corridor is served by 41 active Indian exporters, with an average shipment value of $18.6K USD. The leading Indian exporter is INDOCO REMEDIES LIMITED, which accounts for 31% of total export value with 63 shipments worth $1.8M USD. On the buying side, PLANET PHARMA is the largest importer in France with $1.6M USD in purchases. The top 3 suppliers — INDOCO REMEDIES LIMITED, CAPLIN POINT LABORATORIES LIMITED, NIYA HEALTHCARE PRIVATE LIMITED — together control 47% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to France Albendazole corridor is one of India's established pharmaceutical export routes, with 314 shipments documented worth a combined $5.8M USD. The route is dominated by INDOCO REMEDIES LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 41 active suppliers, the average shipment value stands at $18.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 13.4%, placing it at rank #13 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in France include PLANET PHARMA, NA, PIEX SOCIETE PHARMACEUTIQUE and 39 others. PLANET PHARMA is the single largest importer with 107 shipments valued at $1.6M USD.
